Reports for TAKEDA CANADA INC
Company Name
TAKEDA CANADA INC
Totals |
||
Shortage reports |
53 |
|
Actual shortage: | 0 (0%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 53 (100%) | |
Discontinuation Reports |
10 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 10 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MEZAVANT | 1.2G | TABLET (DELAYED AND EXTENDED RELEASE) | Resolved | 2020-01-15 | 2020-08-22 | 103353 |
MEZAVANT | 1.2G | TABLET (DELAYED AND EXTENDED RELEASE) | Resolved | 2022-07-18 | 2022-08-19 | 164835 |
MEZAVANT | 1.2G | TABLET (DELAYED AND EXTENDED RELEASE) | Resolved | 2022-10-14 | 2022-11-02 | 171844 |
GAMMAGARD LIQUID | 10% | SOLUTION | Resolved | 2019-07-31 | 2020-02-06 | 90434 |
RIXUBIS | 1000UNIT | POWDER FOR SOLUTION KIT | Resolved | 2021-07-07 | 2021-08-26 | 141947 |
RIXUBIS | 1000UNIT | POWDER FOR SOLUTION KIT | Resolved | 2023-07-13 | 2023-08-28 | 198631 |
VYVANSE | 10MG | CAPSULE | Resolved | 2017-04-06 | 2017-04-13 | 5797 |
VYVANSE | 10MG | CAPSULE | Resolved | 2018-07-06 | 2018-07-14 | 54721 |
VYVANSE | 10MG | CAPSULE | Resolved | 2021-09-22 | 2021-10-07 | 146027 |
VYVANSE | 10MG | CAPSULE | Resolved | 2022-06-03 | 2022-07-08 | 161811 |
VYVANSE | 10MG | CAPSULE | Resolved | 2023-08-30 | 2023-09-14 | 203355 |
VYVANSE | 10MG | CAPSULE | Resolved | 2024-02-27 | 2024-03-18 | 220802 |
VYVANSE | 10MG | TABLET (CHEWABLE) | Resolved | 2021-12-02 | 2021-12-12 | 150423 |
ANTITHROMBIN III NF | 1100UNIT | KIT POWDER FOR SOLUTION | Resolved | 2020-11-13 | 2020-12-02 | 128404 |
FEIBA NF | 1300UNIT | POWDER FOR SOLUTION KIT | Resolved | 2021-02-25 | 2021-04-12 | 134686 |
FEIBA NF | 1300UNIT | KIT POWDER FOR SOLUTION | Resolved | 2021-06-04 | 2021-06-25 | 140472 |
RIXUBIS | 2000UNIT | POWDER FOR SOLUTION KIT | Resolved | 2023-07-13 | 2023-08-28 | 198627 |
CUVITRU | 200MG | SOLUTION | Resolved | 2019-04-29 | 2019-08-24 | 82602 |
VYVANSE | 20MG | CAPSULE | Resolved | 2023-06-23 | 2023-10-07 | 196238 |
FOSRENOL | 250MG | TABLET (CHEWABLE) | Resolved | 2018-06-04 | 2018-07-14 | 51338 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
AGRYLIN | 0.5MG | CAPSULE | Discontinued | 2023-11-14 | 2024-03-01 | 210182 |
FOSRENOL | 1000MG | TABLET (CHEWABLE) | Discontinued | 2024-05-16 | 2024-08-01 | 228184 |
ACTOS | 15MG | TABLET | Discontinued | 2018-04-02 | 2018-04-02 | 44428 |
FOSRENOL | 250MG | TABLET (CHEWABLE) | Discontinued | 2022-12-19 | 2023-04-30 | 178916 |
ACTOS | 30MG | TABLET | Discontinued | 2018-04-02 | 2018-04-02 | 44433 |
PANTO IV | 40MG | POWDER FOR SOLUTION | Discontinued | 2017-03-15 | 2017-03-15 | 2969 |
ACTOS | 45MG | TABLET | Discontinued | 2018-04-02 | 2018-04-02 | 44438 |
FOSRENOL | 500MG | TABLET (CHEWABLE) | Discontinued | 2024-05-16 | 2024-06-10 | 228178 |
FOSRENOL | 750MG | TABLET (CHEWABLE) | Discontinued | 2024-05-16 | 2024-08-01 | 228181 |
ULORIC | 80MG | TABLET | Discontinued | 2021-08-17 | 2022-01-04 | 144266 |
Showing 1 to 10 of 10